Clovis Oncology, Inc. (CLVS) has 227 open-market insider trades by 33 insiders since 2011. The most active filer is Gillian C. Ivers-read.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Parters Vii L. P. Domain | 10% | — | 2 | $22.2M | 2013-06-04 |
| Kathleen K. Schoemaker | 10% | — | 3 | $18.4M | 2013-06-04 |
| M. James Barrett | Dir | — | 3 | $17.5M | 2017-02-27 |
| Forest Baskett | 10% | — | 1 | $17.1M | 2013-06-03 |
| Patrick J. Kerins | 10% | — | 1 | $17.1M | 2013-06-03 |
| Scott D. Sandell | 10% | — | 1 | $17.1M | 2013-06-03 |
| David M. Mott | 10% | — | 1 | $17.1M | 2013-06-03 |
| Krishna Kittu Kolluri | 10% | — | 1 | $17.1M | 2013-06-03 |
| NEA 13 GP, Ltd | 10% | — | 1 | $17.1M | 2013-06-03 |
| Ravi Viswanathan | 10% | — | 1 | $17.1M | 2013-06-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Paul Edward Gross | — | Sell | $5K | 2022-11-02 |
| Gillian C. Ivers-read | — | Sell | $4K | 2022-11-02 |
| Lindsey Rolfe | — | Sell | $4K | 2022-11-02 |
| Thomas C. Harding | — | Sell | $2K | 2022-11-02 |
| Daniel W. Muehl | — | Sell | $4K | 2022-11-02 |
| Thomas C. Harding | — | Sell | $8 | 2022-10-03 |
Companies that share insiders with CLVS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul Edward Gross | — | Sell | $3K | 2022-09-02 |
| Lindsey Rolfe | — | Sell | $3K | 2022-09-02 |
| Thomas C. Harding | — | Sell | $2K | 2022-09-02 |
| Daniel W. Muehl | — | Sell | $3K | 2022-09-02 |
| Lindsey Rolfe | — | Sell | $6K | 2022-08-02 |
| Thomas C. Harding | — | Sell | $3K | 2022-08-02 |
| Paul Edward Gross | — | Sell | $7K | 2022-08-02 |
| Daniel W. Muehl | — | Sell | $7K | 2022-08-02 |
| Gillian C. Ivers-read | — | Sell | $6K | 2022-08-02 |